CVS Health Co. (NYSE:CVS) Stock Holdings Increased by Wealth Enhancement Advisory Services LLC

Wealth Enhancement Advisory Services LLC lifted its position in shares of CVS Health Co. (NYSE:CVS - Free Report) by 67.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 286,990 shares of the pharmacy operator's stock after purchasing an additional 115,603 shares during the period. Wealth Enhancement Advisory Services LLC's holdings in CVS Health were worth $12,883,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of CVS. Whitebox Advisors LLC acquired a new position in CVS Health in the fourth quarter valued at $249,000. B&D White Capital Company LLC purchased a new position in CVS Health in the 4th quarter valued at $417,000. Fairfax Financial Holdings Ltd. Can purchased a new position in CVS Health during the fourth quarter worth about $121,742,000. Lazard Asset Management LLC boosted its stake in shares of CVS Health by 7.3% in the fourth quarter. Lazard Asset Management LLC now owns 4,290,953 shares of the pharmacy operator's stock valued at $192,617,000 after buying an additional 293,406 shares in the last quarter. Finally, Seizert Capital Partners LLC lifted its stake in shares of CVS Health by 22.8% in the fourth quarter. Seizert Capital Partners LLC now owns 569,527 shares of the pharmacy operator's stock valued at $25,566,000 after purchasing an additional 105,708 shares during the period. Institutional investors and hedge funds own 80.66% of the company's stock.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on CVS. Robert W. Baird upped their price target on shares of CVS Health from $51.00 to $71.00 and gave the company a "neutral" rating in a report on Tuesday, April 15th. Royal Bank of Canada raised their price objective on CVS Health from $74.00 to $81.00 and gave the stock an "outperform" rating in a report on Monday, May 5th. Wall Street Zen upgraded shares of CVS Health from a "hold" rating to a "buy" rating in a report on Friday, May 9th. Piper Sandler upped their target price on CVS Health from $72.00 to $74.00 and gave the stock an "overweight" rating in a research report on Friday, March 21st. Finally, Cowen reiterated a "buy" rating on shares of CVS Health in a report on Monday, May 5th. Two analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, CVS Health has a consensus rating of "Moderate Buy" and an average price target of $74.75.

CVS Health Stock Performance

Shares of NYSE:CVS traded down $0.45 during trading on Monday, reaching $63.60. 6,674,441 shares of the company's stock traded hands, compared to its average volume of 11,195,127. The stock has a market capitalization of $80.45 billion, a P/E ratio of 17.38, a price-to-earnings-growth ratio of 0.98 and a beta of 0.60. CVS Health Co. has a 12 month low of $43.56 and a 12 month high of $72.51. The company has a 50 day moving average of $65.62 and a 200-day moving average of $59.67. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.81 and a quick ratio of 0.60.

CVS Health (NYSE:CVS - Get Free Report) last posted its earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 EPS for the quarter, beating the consensus estimate of $1.62 by $0.63. The company had revenue of $94.59 billion during the quarter, compared to analyst estimates of $93.07 billion. CVS Health had a return on equity of 9.11% and a net margin of 1.24%. The business's revenue was up 7.0% compared to the same quarter last year. During the same period in the prior year, the company earned $1.31 earnings per share. On average, equities analysts expect that CVS Health Co. will post 5.89 EPS for the current year.

CVS Health Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, May 1st. Shareholders of record on Tuesday, April 22nd were paid a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a yield of 4.18%. The ex-dividend date was Tuesday, April 22nd. CVS Health's payout ratio is 63.48%.

Insider Activity

In related news, SVP James David Clark sold 7,513 shares of CVS Health stock in a transaction dated Wednesday, March 5th. The shares were sold at an average price of $66.35, for a total value of $498,487.55. Following the sale, the senior vice president now directly owns 8,394 shares in the company, valued at $556,941.90. This trade represents a 47.23% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Corporate insiders own 1.22% of the company's stock.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.